glp 1 microdosing schedule GLP-1 Explained GLP-1 Microdosing Chart: Tirzepatide and

However, over the next year, initiation slowed and even reversed: with first-time prescribing rates declining 31% by June 2025, reflecting an average month-over-month decrease of 0.004 percentage points

Allow patient to choose site for injection

See What Our Customers Are Saying

Some users may try higher dosages, but starting conservative is recommended 1

This typically manifests as increased fine lines, thinning skin, or generally worse appearance despite consistent product use

Not every patient achieves the weight loss targets they are hoping for, and a meaningful proportion of patients even on maximum doses do not reach the 1520% body weight reduction that clinical guidelines increasingly use as a benchmark for meaningful metabolic benefit